Rhythm Pharmaceuticals

+$0.22 (+1.75%) Today
-$0.12 (-0.94%) As of 12:47 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.

About RYTM

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing peptide therapeutics for the treatment of gastrointestinal diseases and genetic deficiencies. The firm focuses on the treatment for Prader-Willi Syndrome and Pro-Opiomelanocortin deficiency obesity.

CEO
David P. Meeker
Employees
90
Headquarters
Boston, Massachusetts
Founded
2008

RYTM Key Statistics

Market Cap
642.91M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
205.10K
High Today
$12.80
Low Today
$12.22
Open Price
$12.59
Volume
95.32K
52 Week High
$43.26
52 Week Low
$11.53

RYTM Earnings

-$0.89
-$0.59
-$0.30
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 1, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure